SMA gene therapy

Zolgensma Gene Therapy Spinal muscular atrophy (SMA) represents one of the most devastating genetic neuromuscular

Zolgensma (onasemnogene abeparvovec-xioi) is a one-time, potentially transformative gene therapy that has redefined treatment possibilities

Zolgensma (onasemnogene abeparvovec-xioi) stands as one of the most groundbreaking one-time gene therapies ever approved

Introduction Zolgensma has emerged as a transformative gene therapy for spinal muscular atrophy (SMA), a

Spinal Muscular Atrophy (SMA) is a rare and often devastating genetic disease affecting thousands of

Introduction: A New Era in Genetic Medicine The advent of gene therapy has revolutionized the